Albumin Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2026

Jul 2018| TMR750A| Transparency

Report Highlights

Global Albumin (as Excipient) Market: Overview
This report analyzes the global albumin (as excipient) market in terms of its current and future business prospects. Grant of regulatory approvals and subsequent launch of albumin-based products, increasing participation from the pharmaceutical industry in the development and manufacturing of biopharmaceuticals, along with rise in research & development expenditure and increase in consumption of albumin are the key factors driving the growth of the global albumin (as excipient) market. Albumin serves as an important ingredient for formulated proteins and as a component of culture media and other biotech products, ultimately acting as a multifunctional excipient. Use of a well-characterized multifunctional excipient eliminates the time consumed during characterization of each excipient for different functions. This reduces the associated cost, shortens the registration process, and creates a faster route toward the market. Other factors, such as, decrease in issues with variability in quality, lower lot-to-lot and supplier-to-supplier variation, and reduction in the time involved in formulation optimization also drive the demand for albumin as excipient.

This report on albumin (as excipient) market comprises an elaborate executive summary, which includes a market snapshot, providing information on the various segments of the market. It also provides information and data analysis of the global market with respect to its segments based on product, application, end-user and geography. A detailed qualitative analysis of drivers, restraints, and opportunities of the market has been provided in the market overview section of the report. In addition, it comprises competitive matrix and company profiles with business overview to understand the competition in the market. The section also provides market attractiveness analysis, by geography, and market share analysis, in terms of key players, thus presenting a thorough analysis of the overall competitive scenario in the albumin (as excipient) market.

Global Albumin (as Excipient) Market: Key Segments
In terms of product, the global albumin (as excipient) market has been segmented into human serum albumin and recombinant albumin. Based on application, the global market has been divided into human serum albumin applications and recombinant albumin applications. The human serum albumin application segment has further been classified into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. The recombinant albumin segment has further been bifurcated into drug formulation, drug delivery, vaccines, medical device coating, culture medium & stabilizers, diagnostics, and in vitro fertilization. Market size and forecast for each of these segments have been provided in terms of US$ Mn for the period of 2016 to 2026, along with their respective CAGRs, for the forecast period of 2018 to 2026, considering 2017 as the base year.

Global Albumin (as Excipient) Market: Regional Outlook
Geographically, the global albumin (as excipient) market has been categorized into four major regions and key countries in the respective regions: North America (the U.S. and Canada), Europe (the U.K., Germany, France, Spain, Italy, and Rest of Europe), Asia Pacific (India, China, Japan, Australia, and Rest of Asia Pacific), Rest of the World (Brazil, Mexico, South Africa, Saudi Arabia). Market size and forecast for each of these regions and countries have been provided for the period of 2016 to 2026, along with their respective CAGRs for the forecast period of 2018 to 2026, considering 2017 as the base year. The research study also covers the competitive scenario of the albumin (as excipient) market in these regions.

Companies Profiled in the Report
The report also profiles major players operating in the global albumin (as excipient) market based on various attributes, such as, company overview, financial overview, product portfolio, business strategies, and recent developments. Major players in the market are Albumedix A/S (Novozyme A/S), Albumin Therapeutics, LLC, Biotest AG, CSL Behring LLC, Grifols International, S.A, HiMedia Laboratories Pvt. Ltd., InVitria, Medxbio Pte Ltd, Octapharma AG, RayBiotech, Inc., SeraCare Life Sciences, and Sigma-Aldrich Co. (Merck KGaA).

The global albumin (as excipient) market has been segmented as given below:

Product
Human Serum Albumin
Recombinant Albumin
Application
Human Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
Recombinant Albumin Applications
Serum Albumin Applications
Drug Formulation
Drug Delivery
Vaccines
Medical Device Coating
Culture Medium & Stabilizer
Diagnostics
In Vitro Fertilization
End-user
Pharmaceutical & Biotechnology Industry
Research Institutes
Others

Global Pediatric Health Care Products and Services Market, by Geography
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Spain
Rest of Europe
Asia Pacific
China
Japan
India
Australia
Rest of Asia Pacific
Rest of the World

  • Table 1 : Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 2 : Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
  • Table 3 : Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Application, 2016–2026
  • Table 4 : Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
  • Table 5 : Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Human Serum Albumin Applications), 2016–2026
  • Table 6 : Global Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
  • Table 7 : Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Application (Recombinant Albumin Applications), 2016–2026
  • Table 8 : Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 9 : Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, by Region, 2016–2026
  • Table 10 : Global Albumin (as Excipient) Market Volume (Kg) Forecast, by Region, 2016–2026
  • Table 11 : North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country, 2016–2026
  • Table 12 : North America Albumin (as Excipient) Market Volume (kg) Forecast, by Country, 2016–2026
  • Table 13 : North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 14 : North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
  • Table 15 : North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 16 : North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 17 : North America Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 18 : North America Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 19 : North America Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 20 : Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 21 : Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Country/Sub-region, 2016–2026
  • Table 22 : Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 23 : Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
  • Table 24 : Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 25 : Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 26 : Europe Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 27 : Europe Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 28 : Europe Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 29 : Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2016–2026
  • Table 30 : Asia Pacific Albumin (as Excipient) Market Volume (kg) Forecast, by Country/Sub-region, 2016–2026
  • Table 31 : Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 32 : Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
  • Table 33 : Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 34 : Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 35 : Asia Pacific Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 36 : Asia Pacific Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 37 : Asia Pacific Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Table 38 : Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Product, 2016–2026
  • Table 39 : Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Product, 2016–2026
  • Table 40 : Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 41 : Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Human Serum Albumin Applications, 2016–2026
  • Table 42 : Rest of the World Albumin (as Excipient) Market Value (US$ Mn) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 43 : Rest of the World Albumin (as Excipient) Market Volume (Kg) Forecast, by Recombinant Albumin Applications, 2016–2026
  • Table 44 : Rest of the World Albumin (as Excipient) Market Size (US$ Mn) Forecast, by End-user, 2016–2026
  • Figure 1 : Global Albumin (as Excipient) Market Size (US$ Mn) Forecast, 2016–2026
  • Figure 2 : Global Albumin (as Excipient) Market Volume (Kg) Forecast, 2016–2026
  • Figure 3 : Global Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
  • Figure 4 : Global Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
  • Figure 5 : Global Albumin (as Excipient) Market Revenue (US$ Mn), by Human Serum Albumin, 2016–2026
  • Figure 6 : Global Albumin (as Excipient) Market Revenue (US$ Mn), by Recombinant Albumin, 2016–2026
  • Figure 7 : Global Albumin (as Excipient) Market Value Share, by Application, 2017 and 2026
  • Figure 8 : Global Albumin (as Excipient) Market Attractiveness, by Application, 2018–2026
  • Figure 9 : Global Albumin (as Excipient) Market Value Share, by Application (Human Serum Albumin), 2017 and 2026
  • Figure 10 : Global Albumin (as Excipient) Market Attractiveness, by Application (Recombinant Albumin), 2017 and 2026
  • Figure 11 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Formulation, 2016–2026
  • Figure 12 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery, 2016–2026
  • Figure 13 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
  • Figure 14 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Device Coating, 2016–2026
  • Figure 15 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Media & Stabilizers, 2016–2026
  • Figure 16 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2016–2026
  • Figure 17 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro Fertilization, 2016–2026
  • Figure 18 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Formulation, 2016–2026
  • Figure 19 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Drug Delivery, 2016–2026
  • Figure 20 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Vaccines, 2016–2026
  • Figure 21 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Medical Device Coating, 2016–2026
  • Figure 22 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Culture Media & Stabilizers, 2016–2026
  • Figure 23 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Diagnostics, 2016–2026
  • Figure 24 : Global Albumin (as Excipient) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by In Vitro Fertilization, 2016–2026
  • Figure 25 : Global Albumin (as Excipient) Market Attractiveness, by Application (Human Serum Albumin), 2018 - 2026
  • Figure 26 : Global Albumin (as Excipient) Market Attractiveness, by Application (Recombinant Albumin), 2018–2026
  • Figure 27 : Global Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
  • Figure 28 : Global Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
  • Figure 29 : Global Albumin (as Excipient) Market Revenue (US$ Mn), by Pharmaceutical & Biotechnology Industry, 2016–2026
  • Figure 30 : Global Albumin (as Excipient) Market Revenue (US$ Mn), by Research Institutes, 2016–2026
  • Figure 31 : Global Albumin (as Excipient) Market Revenue (US$ Mn), by Others, 2016–2026
  • Figure 32 : Global Albumin (as Excipient) Market Value Share Analysis, by Region, 2017 and 2026
  • Figure 33 : Global Albumin (as Excipient) Market Attractiveness Analysis, by Region
  • Figure 34 : North America Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 35 : North America Albumin (as Excipient) Market Value Share, by Country, 2017 and 2026
  • Figure 36 : North America Albumin (as Excipient) Market Attractiveness, by Country, 2018–2026
  • Figure 37 : North America Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
  • Figure 38 : North America Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
  • Figure 39 : North America Albumin (as Excipient) Market Value Share, by Human Serum Albumin Application, 2017 and 2026
  • Figure 40 : North America Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Application, 2018–2026
  • Figure 41 : North America Albumin (as Excipient) Market Value Share, by Recombinant Albumin Application, 2017 and 2026
  • Figure 42 : North America Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Application, 2018–2026
  • Figure 43 : North America Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
  • Figure 44 : North America Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
  • Figure 45 : Europe Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 46 : Europe Albumin (as Excipient) Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 47 : Europe Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 48 : Europe Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
  • Figure 49 : Europe Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
  • Figure 50 : Europe Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
  • Figure 51 : Europe Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
  • Figure 52 : Europe Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
  • Figure 53 : Europe Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
  • Figure 54 : Europe Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
  • Figure 55 : Europe Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
  • Figure 56 : Asia Pacific Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 57 : Asia Pacific Albumin (as Excipient) Market Value Share, by Country/Sub-region, 2017 and 2026
  • Figure 58 : Asia Pacific Albumin (as Excipient) Market Attractiveness, by Country/Sub-region, 2018–2026
  • Figure 59 : Asia Pacific Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
  • Figure 60 : Asia Pacific Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
  • Figure 61 : Asia Pacific Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
  • Figure 62 : Asia Pacific Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
  • Figure 63 : Asia Pacific Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
  • Figure 64 : Asia Pacific Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
  • Figure 65 : Asia Pacific Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
  • Figure 66 : Asia Pacific Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026
  • Figure 67 : Rest of the World Albumin (as Excipient) Market Size (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2018–2026
  • Figure 68 : Rest of the World Albumin (as Excipient) Market Value Share, by Product, 2017 and 2026
  • Figure 69 : Rest of the World Albumin (as Excipient) Market Attractiveness, by Product, 2018–2026
  • Figure 70 : Rest of the World Albumin (as Excipient) Market Value Share, by Human Serum Albumin Applications, 2017 and 2026
  • Figure 71 : Rest of the World Albumin (as Excipient) Market Attractiveness, by Human Serum Albumin Applications, 2018–2026
  • Figure 72 : Rest of the World Albumin (as Excipient) Market Value Share, by Recombinant Albumin Applications, 2017 and 2026
  • Figure 73 : Rest of the World Albumin (as Excipient) Market Attractiveness, by Recombinant Albumin Applications, 2018–2026
  • Figure 74 : Rest of the World Albumin (as Excipient) Market Value Share, by End-user, 2017 and 2026
  • Figure 75 : Rest of the World Albumin (as Excipient) Market Attractiveness, by End-user, 2018–2026

Leaders in analytics, research and advisory services for Fortune 500 companies, scores of high potential startups, and financial institutions. Our success stories have proven why we are a prominent provider of a cutting-edge syndicated and customized research services. Leverage the best of our seasoned research analysts who had a keen interest and enviable expertise of almost 4 million hours in global, regional, and local market intelligence.

Why BCC Research?

Every purchase provides access to:

  • Thousands of recently published reports from select publishers
  • Member Discounts of up to 50% on over 20,000 additional reports from all publishers
  • Our analysts and research concierge for all inquiries
CUSTOM RESEARCH

Need a custom data table, graph or complete report? Tell us more.

Contact Us
Share This Report